These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35417006)

  • 1. COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
    Cortellini A; Gennari A; Pommeret F; Patel G; Newsom-Davis T; Bertuzzi A; Viladot M; Aguilar-Company J; Mirallas O; Felip E; Lee AJX; Dalla Pria A; Sharkey R; Brunet J; Carmona-García M; Chester J; Mukherjee U; Scotti L; Dolly S; Sita-Lumsden A; Ferrante D; Van Hemelrijck M; Moss C; Russell B; Seguí E; Biello F; Krengli M; Marco-Hernández J; Gaidano G; Patriarca A; Bruna R; Roldán E; Fox L; Pous A; Griscelli F; Salazar R; Martinez-Vila C; Sureda A; Loizidou A; Maluquer C; Stoclin A; Iglesias M; Pedrazzoli P; Rizzo G; Santoro A; Rimassa L; Rossi S; Harbeck N; Sanchez de Torre A; Vincenzi B; Libertini M; Provenzano S; Generali D; Grisanti S; Berardi R; Tucci M; Mazzoni F; Lambertini M; Tagliamento M; Parisi A; Zoratto F; Queirolo P; Giusti R; Guida A; Zambelli A; Tondini C; Maconi A; Betti M; Colomba E; Diamantis N; Sinclair A; Bower M; Ruiz-Camps I; Pinato DJ;
    J Natl Cancer Inst; 2022 Jul; 114(7):979-987. PubMed ID: 35417006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
    Pinato DJ; Tabernero J; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Saponara M; Cruz CA; García-Illescas D; Felip E; Roqué Lloveras A; Sharkey R; Roldán E; Reyes R; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Cantini L; Filetti M; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Van Hemelrijck M; Diamantis N; Newsom-Davis T; Gennari A; Cortellini A;
    Lancet Oncol; 2021 Dec; 22(12):1669-1680. PubMed ID: 34741822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
    Cortellini A; Tabernero J; Mukherjee U; Salazar R; Sureda A; Maluquer C; Ferrante D; Bower M; Sharkey R; Mirallas O; Plaja A; Cucurull M; Mesia R; Dalla Pria A; Newsom-Davis T; Van Hemelrijck M; Sita-Lumsden A; Apthorp E; Vincenzi B; Di Fazio GR; Tonini G; Pantano F; Bertuzzi A; Rossi S; Brunet J; Lambertini M; Pedrazzoli P; Biello F; D'Avanzo F; Lee AJX; Shawe-Taylor M; Rogers L; Murphy C; Cooper L; Andaleeb R; Khalique S; Bawany S; Ahmed S; Carmona-García MC; Fort-Culillas R; Liñan R; Zoratto F; Rizzo G; Perachino M; Doonga K; Gaidano G; Bruna R; Patriarca A; Martinez-Vila C; Pérez Criado I; Giusti R; Mazzoni F; Antonuzzo L; Santoro A; Parisi A; Queirolo P; Aujayeb A; Rimassa L; Diamantis N; Bertulli R; Fulgenzi CAM; D'Alessio A; Ruiz-Camps I; Saoudi-Gonzalez N; Garcia Illescas D; Medina I; Fox L; Gennari A; Aguilar-Company J; Pinato DJ;
    Lancet Oncol; 2023 Apr; 24(4):335-346. PubMed ID: 36898391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Study of Clinical Features of COVID-19 in Inpatients and Their Association with Disease Severity.
    Wang H; Xing Y; Yao X; Li Y; Huang J; Tang J; Zhu S; Zhang Y; Xiao J
    Med Sci Monit; 2020 Dec; 26():e927674. PubMed ID: 33342993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry.
    Cortellini A; Salazar R; Gennari A; Aguilar-Company J; Bower M; Bertuzzi A; Brunet J; Lambertini M; Maluquer C; Pedrazzoli P; Lee AJ; Carmona-García M; Newsom-Davis T; Van Hemelrijck M; Plaja A; Zambelli A; Tondini C; Generali D; Bertulli R; Diamantis N; Mukherjee U; Rizzo G; Yu T; Zoratto F; Bruna R; Sureda A; Martinez-Vila C; Cantini L; Mazzoni F; Grosso F; Parisi A; Saponara M; Prat A; Pinato DJ;
    Eur J Cancer; 2022 Jul; 170():10-16. PubMed ID: 35576848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].
    Fei M; Tong F; Tao X; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):554-558. PubMed ID: 32576346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine laboratory testing to determine if a patient has COVID-19.
    Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
    Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
    J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic accuracy of inflammatory markers in predicting risk of ICU admission for COVID-19: application of time-dependent receiver operating characteristic curves.
    Geraili Z; Hajian-Tilaki K; Bayani M; Hosseini SR; Khafri S; Ebrahimpour S; Javanian M; Babazadeh A; Shokri M
    J Int Med Res; 2022 Jun; 50(6):3000605221102217. PubMed ID: 35701893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries.
    Cortellini A; Dettorre GM; Dafni U; Aguilar-Company J; Castelo-Branco L; Lambertini M; Gennatas S; Angelis V; Sita-Lumsden A; Rogado J; Pedrazzoli P; Viñal D; Prat A; Rossi M; Berardi R; Alonso-Gordoa T; Grisanti S; Dimopoulou G; Queirolo P; Pradervand S; Bertuzzi A; Bower M; Arnold D; Salazar R; Tucci M; Harrington KJ; Mazzoni F; Mukherjee U; Tsourti Z; Michielin O; Pommeret F; Brunet J; Vincenzi B; Tonini G; Patriarca A; Biello F; Krengli M; Tabernero J; Pentheroudakis G; Gennari A; Peters S; Romano E; Pinato DJ
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36450384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
    Dettorre GM; Dolly S; Loizidou A; Chester J; Jackson A; Mukherjee U; Zambelli A; Aguilar-Company J; Bower M; Sng CCT; Salazar R; Bertuzzi A; Brunet J; Mesia R; Sita-Lumsden A; Seguí E; Biello F; Generali D; Grisanti S; Seeva P; Rizzo G; Libertini M; Maconi A; Moss C; Russell B; Harbeck N; Vincenzi B; Bertulli R; Ottaviani D; Liñan R; Marrari A; Carmona-García MC; Chopra N; Tondini CA; Mirallas O; Tovazzi V; Fotia V; Cruz CA; Saoudi-Gonzalez N; Felip E; Roqué A; Lee AJX; Newsom-Davis T; García-Illescas D; Reyes R; Wong YNS; Ferrante D; Scotti L; Marco-Hernández J; Ruiz-Camps I; Patriarca A; Rimassa L; Chiudinelli L; Franchi M; Santoro A; Prat A; Gennari A; Van Hemelrijck M; Tabernero J; Diamantis N; Pinato DJ;
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of C-reactive protein/albumin, fibrinogen/albumin, and neutrophil/lymphocyte ratios in predicting the severity of CoVID-19.
    Torun A; Çakırca TD; Çakırca G; Portakal RD
    Rev Assoc Med Bras (1992); 2021 Mar; 67(3):431-436. PubMed ID: 34468610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematological characteristics of COVID-19 patients with fever infected by the Omicron variant in Shanghai: A retrospective cohort study in China.
    Wei T; Li J; Cheng Z; Jiang L; Zhang J; Wang H; Zhou L
    J Clin Lab Anal; 2023 Jan; 37(1):e24808. PubMed ID: 36525342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
    Wang X; Li X; Shang Y; Wang J; Zhang X; Su D; Zhao S; Wang Q; Liu L; Li Y; Chen H
    Epidemiol Infect; 2020 Sep; 148():e211. PubMed ID: 32900409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
    Yao C; Liu X; Tang Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).
    Yufei Y; Mingli L; Xuejiao L; Xuemei D; Yiming J; Qin Q; Hui S; Jie G
    Scand J Clin Lab Invest; 2020 Nov; 80(7):536-540. PubMed ID: 32804580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of immune-inflammatory markers in predicting clinical outcome of COVID-19 patients.
    Singh A; Bhadani PP; Surabhi ; Sinha R; Bharti S; Kumar T; Nigam JS
    Indian J Pathol Microbiol; 2023; 66(1):111-117. PubMed ID: 36656221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].
    Chen Y; Wang KJ; Luo YC; Wang BZ; Zhang MM; Xu YQ; Yang YN; Ma YT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):572-579. PubMed ID: 32842269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.